During the past decade, Reumatika Centrum Reumatologii nzoz conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 23 clinical trials were completed, i.e. on average, 95.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 15 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reumatika Centrum Reumatologii nzoz" #1 sponsor was "Pfizer" with 11 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reumatika Centrum Reumatologii nzoz" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Reumatika Centrum Reumatologii nzoz" are "Psoriatic Arthritis" (5 trials), "Rheumatoid Arthritis" (5 trials), "Arthritis, Psoriatic" (3 trials), "Arthritis, Rheumatoid" (3 trials) and "Systemic Lupus Erythematosus" (3 trials). Many other conditions were trialed in "Reumatika Centrum Reumatologii nzoz" in a lesser frequency.

Most popular intervention types in "Reumatika Centrum Reumatologii nzoz" are "Drug" (27 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Tofacitinib" (5 trials), "Guselkumab" (4 trials), "Baricitinib" (3 trials) and "Golimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Reumatika Centrum Reumatologii nzoz" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Reumatika Centrum Reumatologii nzoz". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Reumatika Centrum Reumatologii nzoz, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Reumatika Centrum Reumatologii nzoz, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Reumatika Centrum Reumatologii nzoz has several departments that took part in Clinical trials: "Ars Rheumatica Sp. Z.o.o." - 6 trials